Company Response to NSE Volume Query
Date and Nature of Exchange Query
Astec LifeSciences Limited received a notice from the National Stock Exchange of India Limited (NSE) on 17th September 2026, bearing Reference No. NSE/CM/Surveillance/17561. The notice specifically addressed a significant increase in the trading volume of the company's security across exchanges in the recent past.
Company's Clarification on Trading Volume
In response to the NSE query, the company stated that as a listed entity, it is conscious of its responsibility to disseminate information that could impact share prices. The company confirmed it has been promptly disclosing events or information required under Regulation 30 of the SEBI Listing Obligations and Disclosure Requirements Regulations, 2015.
The company specifically confirmed that there are no developments requiring mandatory disclosure under either the Listing Regulations or the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015.
Regulatory Compliance Reference
The response explicitly references compliance with:
- Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015
- Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015
The company assured the exchange that it would continue to fully comply with all obligations under these regulations and make appropriate disclosures as mandated when required.
Financial Results Clarification
No specific financial results were discussed or clarified in this communication. The response focused exclusively on the trading volume inquiry and general disclosure compliance.
Conclusion and Attestation
The response was formally signed by Tejashree Pradhan, Company Secretary & Compliance Officer (FCS 7167), who digitally signed the document on 18th September 2026 at 10:45:18 +05'30'.
Topic Tags: Regulatory Response, Stock Trading, Volume Increase, Compliance, SEBI Regulations